I feel like Jon squashed any low ball TO talks again suggesting that this is just the beginning for Neu, start of new phase with all focus on DAYBUE being commercial in particular ROW and NZ-2591 phase 2 trails.
No Divis which suits me, and full focus on bolstering cash in the bank to ensure these assets get to where they need to get to.
I am happy with this as share price appreciation todate has been great from $1.45 for me, now we are digesting the potential $20+ maybe $40 in my view from DAYBUE, but make no mistakes if Phase 2 trials come up positive we are going big here and $100p/sh is well and truely in the hunt.
I can't see it possible for the board to consider a TO offer prior to NZ-2591 results.
Ann: Investor Presentation, 14 March 2023, page-23
-
- There are more pages in this discussion • 123 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.00 |
Change
0.090(0.45%) |
Mkt cap ! $2.556B | |||
| Open | High | Low | Value | Volume |
| $19.88 | $20.07 | $19.73 | $11.80M | 591.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5901 | $19.97 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.00 | 3262 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |